In addition, the presence of isolated EPCAM-negative glands in MSH2-negative colorectal polyps is a hallmark pattern that allows the identification of EPCAM 3′-end deletion carriers, demonstrating its effectiveness when no tumor tissue is available. This evidence concerns the gene MSH2 and polyp of large intestine.